| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - paraffin section; human; 1:40; loading ...; fig 6e
| Corda G, Sala G, Lattanzio R, Iezzi M, Sallese M, Fragassi G, et al. Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer. J Pathol. 2017;241:350-361 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:40; loading ...; fig 4
| Loverro G, Resta L, Dellino M, Edoardo D, Cascarano M, Loverro M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55:686-691 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:50; fig 1b
| McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher |
- immunohistochemistry; human
| Mountzios G, Aivazi D, Kostopoulos I, Kourea H, Kouvatseas G, Timotheadou E, et al. Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes. PLoS ONE. 2014;9:e91407 pubmed publisher |
- immunohistochemistry; human
| Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher |
- immunohistochemistry; human; 1:200; fig 4
| Wang N, Geng L, Zhang S, He B, Wang J. Expression of PRB, FKBP52 and HB-EGF relating with ultrasonic evaluation of endometrial receptivity. PLoS ONE. 2012;7:e34010 pubmed publisher |
| Eng A, McCormack V, dos Santos Silva I. Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001720 pubmed publisher |
| Pinto A, Areia F, Pereira T, Cardoso P, Aparício M, Silva G, et al. Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer. Springerplus. 2013;2:375 pubmed publisher |
| McCallum M, Baker C, Gillespie K, Cohen B, Stewart H, Leonard R, et al. A prognostic index for operable, node-negative breast cancer. Br J Cancer. 2004;90:1933-41 pubmed |
| Milde Langosch K, Goemann C, Methner C, Rieck G, Bamberger A, Löning T. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status. Br J Cancer. 2001;85:546-51 pubmed |
| Reich O, Regauer S, Urdl W, Lahousen M, Winter R. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer. 2000;82:1030-4 pubmed |
